The influence of smoking on the pattern of disability and relapse risk in AQP4-positive Neuromyelitis Optica Spectrum Disorder, MOG-Ab Disease and Multiple Sclerosis.

[1]  T. Chitnis,et al.  Association Between Cigarette Smoking and Multiple Sclerosis: A Review. , 2019, JAMA neurology.

[2]  Jacqueline Palace,et al.  Classifying the antibody-negative NMO syndromes , 2019, Neurology: Neuroimmunology & Neuroinflammation.

[3]  Jacqueline A Palace,et al.  Comparison of Clinical Outcomes of Transverse Myelitis Among Adults With Myelin Oligodendrocyte Glycoprotein Antibody vs Aquaporin-4 Antibody Disease , 2019, JAMA network open.

[4]  M. Maes,et al.  Tumor necrosis factor alpha (TNF-α) and its soluble receptors are associated with disability, disability progression and clinical forms of multiple sclerosis , 2019, Inflammation Research.

[5]  S. Eskandarieh,et al.  Association of cigarette smoking with neuromyelitis optica-immunoglobulin G sero-positivity in neuromyelitis optica spectrum disorder , 2019, Iranian journal of neurology.

[6]  C. Constantinescu,et al.  Effects of cigarette smoke on immunity, neuroinflammation and multiple sclerosis , 2019, Journal of Neuroimmunology.

[7]  F. Paul,et al.  Racial differences in neuromyelitis optica spectrum disorder , 2018, Neurology.

[8]  H. Søndergaard,et al.  Smoking is associated with increased disease activity during natalizumab treatment in multiple sclerosis , 2018, Multiple sclerosis.

[9]  Jacqueline Palace,et al.  Clinical presentation and prognosis in MOG-antibody disease: a UK study , 2017, Brain : a journal of neurology.

[10]  M. Esiri,et al.  Age‐related small vessel disease: a potential contributor to neurodegeneration in multiple sclerosis , 2017, Brain pathology.

[11]  Michelle L Degelman,et al.  Smoking and multiple sclerosis: A systematic review and meta-analysis using the Bradford Hill criteria for causation. , 2017, Multiple sclerosis and related disorders.

[12]  G. DeLuca,et al.  Vascular pathology in multiple sclerosis: reframing pathogenesis around the blood-brain barrier , 2017, Journal of Neurology, Neurosurgery, and Psychiatry.

[13]  Ting-ting Yang,et al.  Association of smoking with risk of multiple sclerosis and neuromyelitis optica spectrum disorders , 2016 .

[14]  T. Holmøy,et al.  No association of tobacco use and disease activity in multiple sclerosis , 2016, Neurology: Neuroimmunology & Neuroinflammation.

[15]  J. Correale,et al.  Smoking and Disease Severity in Patients with Neuromyelitis Optica (P6.162) , 2016 .

[16]  A. Ascherio,et al.  Risk factors for multiple sclerosis, neuromyelitis optica and transverse myelitis , 2015, Multiple sclerosis.

[17]  K. Fujihara,et al.  MOG cell-based assay detects non-MS patients with inflammatory neurologic disease , 2015, Neurology: Neuroimmunology & Neuroinflammation.

[18]  D. Rubenstein,et al.  The combined effect of sidestream smoke and dynamic shear stress on endothelial cell inflammatory responses. , 2015, Thrombosis research.

[19]  A. Straube,et al.  Histopathology and clinical course of MOG-antibody-associated encephalomyelitis , 2015, Annals of clinical and translational neurology.

[20]  R. Rossen,et al.  Activation of C3a receptor is required in cigarette smoke-mediated emphysema , 2014, Mucosal Immunology.

[21]  K. Abbott-Banner,et al.  Effects of cigarette smoke on Toll‐like receptor (TLR) activation of chronic obstructive pulmonary disease (COPD) macrophages , 2014, Clinical and experimental immunology.

[22]  Jacqueline A Palace,et al.  Neuromyelitis optica spectrum disorders with aquaporin-4 and myelin-oligodendrocyte glycoprotein antibodies: a comparative study. , 2014, JAMA neurology.

[23]  Y. Itoyama,et al.  The Pathology of an Autoimmune Astrocytopathy: Lessons Learned from Neuromyelitis Optica , 2014, Brain pathology.

[24]  Jacqueline A Palace,et al.  Longitudinally extensive transverse myelitis with and without aquaporin 4 antibodies. , 2013, JAMA neurology.

[25]  K. Fujihara,et al.  Prognostic factors and disease course in aquaporin-4 antibody-positive patients with neuromyelitis optica spectrum disorder from the United Kingdom and Japan. , 2012, Brain : a journal of neurology.

[26]  Jacqueline Palace,et al.  Serologic diagnosis of NMO , 2012, Neurology.

[27]  D. Wingerchuk.  Smoking: effects on multiple sclerosis susceptibility and disease progression , 2012, Therapeutic advances in neurological disorders.

[28]  H. Tremlett,et al.  The effect of smoking on the symptoms and progression of multiple sclerosis: a review , 2010, Journal of inflammation research.

[29]  D. Postma,et al.  Increased levels of (class switched) memory B cells in peripheral blood of current smokers , 2009, Respiratory research.

[30]  Eman N. Ali,et al.  Smoking and disease progression in multiple sclerosis. , 2009, Archives of neurology.

[31]  Thomais Vlachogianni,et al.  Tobacco Smoke: Involvement of Reactive Oxygen Species and Stable Free Radicals in Mechanisms of Oxidative Damage, Carcinogenesis and Synergistic Effects with Other Respirable Particles , 2009, International journal of environmental research and public health.

[32]  H. Vinters,et al.  Nitric oxide induces necrotic but not apoptotic cell death in oligodendrocytes , 1995, Neuroscience.